Sristi Agro Biotech Profile
Key Indicators
- Authorised Capital ₹ 9.80 M
as on 04-12-2024
- Paid Up Capital ₹ 8.80 M
as on 04-12-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.04 Cr
as on 04-12-2024
- Satisfied Charges ₹ 0.80 M
as on 04-12-2024
- Revenue -89.19%
(FY 2019)
- Profit -181.66%
(FY 2019)
- Ebitda -109.78%
(FY 2019)
- Net Worth -10.83%
(FY 2019)
- Total Assets -4.92%
(FY 2019)
About Sristi Agro Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 9.80 M and a paid-up capital of Rs 8.80 M.
The company currently has active open charges totaling ₹2.04 Cr. The company has closed loans amounting to ₹0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Madan Koley, Snehasis Koley, and Debasis Koley serve as directors at the Company.
- CIN/LLPIN
U01400WB2007PTC114629
- Company No.
114629
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2007
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sristi Agro Biotech Private Limited offer?
Sristi Agro Biotech Private Limited offers a wide range of products and services, including Fresh Flowers, Plants & Trees, Garden Plant, Plant Tissue Culture, Fresh Flower, Banana Tissue Culture Plants, Tissue Cultured Plant, Flowering Plant.
Who are the key members and board of directors at Sristi Agro Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Koley  | Director | 26-Mar-2007 | Current |
| Snehasis Koley | Director | 26-Mar-2007 | Current |
| Debasis Koley | Director | 26-Mar-2007 | Current |
Financial Performance of Sristi Agro Biotech.
Sristi Agro Biotech Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 89.19% decrease. The company also saw a substantial fall in profitability, with a 181.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sristi Agro Biotech?
In 2019, Sristi Agro Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 21 Feb 2012 | ₹2.04 Cr | Open |
Allahabad Bank Creation Date: 27 Mar 2010 | ₹0.80 M | Satisfied |
How Many Employees Work at Sristi Agro Biotech?
Unlock and access historical data on people associated with Sristi Agro Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sristi Agro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sristi Agro Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
